Top Markets
Coin of the day
Merck & Co., Inc. Merck & Co., Inc.

Merck & Co., Inc.

MRK
Hisse Senetlerindeki Sıralama #40
Merck & Co., Inc. is a global healthcare leader with operations spanning two... Merck & Co., Inc. is a global healthcare leader with operations spanning two core divisions: Pharmaceuticals and Animal Health. The Pharmaceutical segment is dedicated to human health, offering a broad spectrum of medicinal products. These cover crucial therapeutic areas such as oncology, acute hospital care, immunology, neuroscience, virology, cardiovascular conditions, and diabetes. This division also develops vital preventive vaccines for pediatric, adolescent, and adult populations. Meanwhile, the Animal Health segment focuses on the research, development, manufacturing, and marketing of veterinary medications, vaccines, and comprehensive health management solutions for animals. This division further provides innovative digital products designed for animal identification, traceability, and continuous monitoring. Merck's extensive clientele encompasses drug wholesalers, pharmacies, hospitals, and government agencies. It also serves managed healthcare organizations, including health maintenance organizations (HMOs) and pharmacy benefit managers, as well as various other institutional clients. Additionally, the company supplies products to individual physicians and their distributors, veterinarians, and livestock producers. The organization actively engages in strategic collaborations with companies such as AstraZeneca PLC, Bayer AG, Eisai Co., Ltd., Ridgeback Biotherapeutics, and Gilead Sciences, Inc. These partnerships are specifically aimed at the joint development and commercialization of prolonged-acting therapies for HIV. Established in 1891, Merck & Co., Inc. maintains its corporate headquarters in Kenilworth, New Jersey.
Hisse Fiyatı
$152.37
Piyasa Değeri
$376.33B
Değişim (1 gün)
12.46%
Değişim (1 yıl)
79.41%
Ülke
US
Ticaret Merck & Co., Inc. (MRK)

Kategori

Merck & Co., Inc. (MRK) için EPS
June 2026 itibariyle EPS TTM: $1.26
Merck & Co., Inc. şirketinin en son finansal raporlarına ve hisse senedi fiyatına göre, şirketin mevcut EPS'si (TTM) $1.26'dir. 2024 yılı sonunda, şirketin EPS'si $6.76 idi; bu, 2023 yılındaki EPS olan $0.14 ile önceki yıla göre artış.
Merck & Co., Inc. için 2000 - 2026 arasındaki EPS geçmişi
Her yıl sonunda EPS
Yıl EPS Değiştir
2026 (TTM) $1.26 -82.69%
2025 $7.28 7.69%
2024 $6.76 4,728.57%
2023 $0.14 -97.56%
2022 $5.73 11.05%
2021 $5.16 84.95%
2020 $2.79 -27.34%
2019 $3.84 60.00%
2018 $2.40 152.63%
2017 $0.95 -54.11%
2016 $2.07 29.38%
2015 $1.60 -61.90%
2014 $4.20 180.00%
2013 $1.50 -31.82%
2012 $2.20 6.80%
2011 $2.06 635.71%
2010 $0.28 -93.25%
2009 $4.15 13.70%
2008 $3.65 -450.96%
2007 $-1.04 -150.98%
2006 $2.04 -3.32%
2005 $2.11 -19.77%
2004 $2.63 -11.45%
2003 $2.97 -6.31%
2002 $3.17 -0.31%
2001 $3.18 7.43%
2000 $2.96 0.00%
Benzer şirketler veya rakipler için EPS
Şirket EPS EPS Farkı Ülke
$29.85 2,269.05%
US
$8.65 586.51%
US
$3.55 181.75%
US
$20.39 1,518.17%
CH
$7.19 470.63%
CH